Bibliography
- JEMEC GBE: Hidradenitis suppurativa. Cutan Med Surg. (2003) 7(1):47–56.
- •The article gives the most recently updated overview of HS.
- VON DER WERTH JM, JEMEC GBE: Morbidity in patients with hidradenitis suppurativa. Br. J. Dermatol. (2001) 144(4):809–813.
- ••Describes the impact of disease.
- VON DER WERTH JM, WILLIAMS HC: The natural history of hidradenitis suppurativa. Eur. Acad. Dermatol. Venereol. (2000) 14(5):389–392.
- ••An important paper in the understandingof the natural course of HS.
- JEMEC GBE, VVENDELBOE P: Topicalclindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. J. Am. Acad. Dermatol. (1998) 39(6):971–974.
- •One of three randomised, controlled trials.
- JEMEC GBE, THOMSEN BM, HANSEN U: The homogeneity of hidradenitis suppurativa lesions. A histological study of intra-individual variation. APMIS (1997) 105(5):378–383.
- GNIADECKI R, JEMEC GBE: Lipid raft-enriched CD29' keratinocytes in the epidermis, hair follicles and sinus tracts in hidradenitis suppurativa. Exp. Dermatol. 13(6):361–363.
- ROMPEL R, PETRES J: Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol. Surg. (2000) 26(7):638–643.
- ••A large case series describing surgery.
- LAPINS J, SARTORIUS K, EMTESTAM L: Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa. J. Am. Acad. Dermatol. (2002) 47(2):280–285.
- GOLD M, BRIDGES TM, BRADSHAW VL, BORING M: ALA-PDT and blue light therapy for hidradenitis suppurativa. J. Drugs Dermatol. (2004) 3(1 Suppl.):832–835.
- LAPINS J, JARSTRAND C, EMTESTAM L: Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery. Br. J. Dermatol. (1999) 140(1):90–95.
- JEMEC GBE, FABER M, GUTSCHIK E, VVENDELBOE P: The bacteriology of hidradenitis suppurativa. Dermatology (1996) 193 (3) : 203–206.
- CLEMMENSEN OJ: Topical treatment of hidradenitis suppurativa with clindamycin. Int. J. Dermatol. (1983) 22(5) :325–328.
- ••The first randomised, controlled trialof HS.
- MORTIMER PS, DAWBER RP, GALES MA, MOORE RA: A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. Br: J. Dermatol. (1986) 115(3):263–268.
- ••One of three randomised, controlled trials.
- STELLON AJ, WAKELING M: Hidradenitis suppurativa associated with use of oral contraceptives. Br. Med. J. (1989) 298(6665):28–29.
- FARRELL AM, RANDALL VA, VAFAEE T, DAWBER RP: Finasteride as a therapy for hidradenitis suppurativa. Br. J. Dermatol. (1999) 141(6):1138–1139.
- GOLDSMITH PC, DOWD PM: Successful therapy of the follicular occlusion triad in a young woman with high dose oral antiandrogens and minocycline. J. R. Soc. Med. (1993) 86(12):729–730.
- CAMISA C, SEXTON C, FRIEDMAN C: Treatment of hidradenitis suppurativa with combination hypothalamic-pituitary-ovarian and adrenal suppression. A case report.' Reprod. Med. (1989) 34(8):543–546.
- HOLST LARSEN T, JEMEC GBE: Acne: comparing hormonal approaches to antibiotics and isotretinoin. Expert Opin. Pharmacother. (2003) 4:1097–1103.
- BOER J, VAN GEMERT MJ: Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa. .1. Am. Acad. Dermatol. (1999) 40(1):73–76.
- ••A large case series.
- FEARFIELD LA, STAUGHTON RC: Severe vulval apocrine acne successfully treated with prednisolone and isotretinoin. Clin. Exp. Dermatol. (1999) 24(3):189–192.
- CHOW ET, MORTIMER PS:Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br. J. Dermatol. (1992) 126(4):415.
- SCHEMAN AJ: Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report. Culls (2002) 69(4):287–288.
- BUCKLEY DA, ROGERS S: Cyclosporin-responsive hidradenitis suppurativa. J. R. Soc. Med. (1995) 88(5):289P-290P
- •This paper reintroduces concept of imrnunosupressive treatment.
- HOFER T, ITIN PH: [Acne inversa: a dapsone-sensitive dermatosis]. Hautarzt (2001) 52(10 Pt 2):989–992.
- JEMEC GBE: Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Gin. Exp. Dermatol. (2002) 27(6):528–529.
- MARTINEZ F, NOS P, BENLLOCH S, PONCE J: Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab. Inflamm. Bowel Dis. (2001) 7(4):323–326.
- SULLIVAN TP, WELSH E, KERDEL FA, BURDICK AE, KIRSNER RS: Infliximab for hidradenitis suppurativa. Br. J. Dermatol. (2003) 149(5):1046–1049.
- •Describes several cases.
- JURGENSMEYER JC, FLEISCHER A: Clinical improvement of refractory hidradenitis suppurativa with etanercept (Poster 58) . JAm. Acad. Dermatol. (2004) 50 (Suppl. 3):15.
Websites
- http://www.angelfire.com/amiga/hssg/